Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C10H12N2O.C4H4O4 |
Molecular Weight | 468.5023 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.CN1[C@@H](CCC1=O)C2=CN=CC=C2.CN3[C@@H](CCC3=O)C4=CN=CC=C4
InChI
InChIKey=NXHGVNVRWLOZDF-SZYUIZJOSA-N
InChI=1S/2C10H12N2O.C4H4O4/c2*1-12-9(4-5-10(12)13)8-3-2-6-11-7-8;5-3(6)1-2-4(7)8/h2*2-3,6-7,9H,4-5H2,1H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*9-;/m00./s1
Molecular Formula | C10H12N2O |
Molecular Weight | 176.2151 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C4H4O4 |
Molecular Weight | 116.0722 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
https://cancercontrol.cancer.gov/brp/tcrb/monographs/7/m7_7.pdf | https://www.ncbi.nlm.nih.gov/pubmed/26972290
Curator's Comment: description was created based on several sources, including:
https://cancercontrol.cancer.gov/brp/tcrb/monographs/7/m7_7.pdf | https://www.ncbi.nlm.nih.gov/pubmed/26972290
Cotinine is a product formed after the chemical nicotine enters the body. Measuring cotinine in people’s blood is the most reliable way to determine exposure to nicotine for both smokers and nonsmokers exposed to environmental tobacco smoke. Cotinine is safe, non-addictive and has pharmacokinetic properties adequate for therapeutic use. Research has shown that cotinine has antipsychotic, anxiolytic, and antidepressant properties and modulates the serotonergic, cholinergic and dopaminergic systems. Cotinine behaves as a positive allosteric modulator of the nicotinic acetylcholine receptors and has anti-inflammatory effects. Cotinine is under investigation as an agent for the treatment of depression, PTSD, schizophrenia, Alzheimer's disease and Parkinson's disease.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24713149 | https://www.ncbi.nlm.nih.gov/pubmed/11974
Curator's Comment: Known to be CNS penetrant in mouse. Human data not available.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Nicotinic acetylcholine receptors alpha3/alpha6/beta2 (Saimiri sciureus) Sources: https://www.ncbi.nlm.nih.gov/pubmed/18305015 |
236.0 µM [EC50] | ||
Target ID: Nicotinic acetylcholine receptors alpha4/beta2 (Saimiri sciureus) Sources: https://www.ncbi.nlm.nih.gov/pubmed/18305015 |
495.0 µM [EC50] | ||
Target ID: CHEMBL2492 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23087643 |
175.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Urine test for the assessment of smoking status. | 2001 |
|
The concentration of three anti-seizure medications in hair: the effects of hair color, controlling for dose and age. | 2001 |
|
[Prevalence of cannabis and tobacco use in patients attending a methadone center. Evaluation by urinary biomarkers]. | 2001 Apr |
|
Accuracy of self-reported cigarette smoking among pregnant women in the 1990s. | 2001 Apr |
|
Infant exposure to environmental tobacco smoke: a prevalence study in Australia. | 2001 Apr |
|
[An appreciation of maternal smoking with high-performance liquid chromatographic determination of maternal and neonatal urinary cotinine]. | 2001 Apr |
|
Cigarette smoking, salivary/gingival crevicular fluid cotinine and periodontal status. A 10-year longitudinal study. | 2001 Apr |
|
Smoking status, reading level, and knowledge of tobacco effects among low-income pregnant women. | 2001 Apr |
|
Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion. | 2001 Aug 1 |
|
Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch. | 2001 Feb |
|
High-performance liquid chromatographic determination of pyridostigmine bromide, nicotine, and their metabolites in rat plasma and urine. | 2001 Jul |
|
A simple high-pressure liquid chromatography cotinine assay: validation of smoking status in pregnant women. | 2001 Jul |
|
Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender. | 2001 Jul |
|
Oltipraz chemoprevention trial in Qidong, People's Republic of China: results of urine genotoxicity assays as related to smoking habits. | 2001 Jul |
|
Saliva cotinine as indicator of cigarette smoking in pregnant women. | 2001 Jul |
|
Trends in the smoking habits of young adults with diabetes. | 2001 Jul |
|
Correlation between nicotine-induced inhibition of hematopoiesis and decreased CD44 expression on bone marrow stromal cells. | 2001 Jul 15 |
|
Prevalence of nicotine consumption in drug deaths. | 2001 Jul 15 |
|
The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). | 2001 Jul 25 |
|
Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus. | 2001 Jul 6 |
|
An integrated approach to prenatal smoking cessation interventions. | 2001 Jul-Aug |
|
Nicotine metabolism and CYP2A6 allele frequencies in Koreans. | 2001 Jun |
|
Individual differences in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes. | 2001 Jun |
|
Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility. | 2001 Jun |
|
Heavily smoking women who cannot quit in pregnancy: evidence of pharmacokinetic predisposition. | 2001 Jun |
|
CYP1B1 expression in human lung. | 2001 Jun |
|
Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. | 2001 Jun |
|
Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. | 2001 Jun 1 |
|
Quantification of nicotine, chlorpyrifos and their metabolites in rat plasma and urine using high-performance liquid chromatography. | 2001 Jun 15 |
|
A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. | 2001 Jun 15 |
|
Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. | 2001 Jun 2 |
|
Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial. | 2001 Jun 9 |
|
Exposure to ethanol and nicotine during the brain growth spurt: spatial DMP performance in male rats. | 2001 Mar |
|
Nicotine metabolism and CYP2D6 phenotype in smokers. | 2001 Mar |
|
Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects. | 2001 Mar 15 |
|
Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes. | 2001 May |
|
CDC unveils body burden. | 2001 May |
|
Lung cancer due to passive smoking--a review. | 2001 May |
|
Household smoking and bronchial hyperresponsiveness in children with asthma. | 2001 May |
|
Effects of smoking cessation and nicotine substitution on systemic eicosanoid production in man. | 2001 May |
|
Preparation of pyridine-N-glucuronides of tobacco-specific nitrosamines. | 2001 May |
|
Science is changing! 300 chemicals and each chemical will have a fingerprint. | 2001 May |
|
Metropolitan home living conditions associated with indoor endotoxin levels. | 2001 May |
|
Adaptation of an enzyme immunoassay to assess urinary cotinine in nonsmokers exposed to tobacco smoke. | 2001 May |
|
Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2'-(14)C]nicotine. | 2001 May |
|
Measures of maternal tobacco exposure and infant birth weight at term. | 2001 May 15 |
|
Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures. | 2001 May 31 |
|
In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. | 2001 May 4 |
|
Systemic nicotine exposure in tobacco harvesters. | 2001 May-Jun |
|
Personal exposures to PM(2.5) and polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke at two locations in Greece. | 2001 May-Jun |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24713149
Mouse: 5 mg/kg during 37 days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9159433
High (190 ug/ml) concentration of Cotinine significantly altered all the sperm kinetic variables in relation to the time of incubation (forward motility, velocity, linearity and beat cross-frequency). Despite the impact seen on these parameters, there was still 30% forward motility after 24 h of incubation.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:10:36 GMT 2023
by
admin
on
Fri Dec 15 15:10:36 GMT 2023
|
Record UNII |
6ZAF060BHS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C73579
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C80524
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
PRIMARY | |||
|
20055460
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
PRIMARY | |||
|
6ZAF060BHS
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
PRIMARY | |||
|
100000138589
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
PRIMARY | |||
|
5695-98-7
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL578211
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
PRIMARY | |||
|
m3811
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB78141
Created by
admin on Fri Dec 15 15:10:37 GMT 2023 , Edited by admin on Fri Dec 15 15:10:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |